VRCAVerrica Pharmaceuticals Inc
VRCA
Verrica Pharmaceuticals Inc2,287
Mkt Cap
$109.43MVolume
25,399.0052W High
$9.8252W Low
$3.28PE Ratio
-3.96VRCA Fundamentals
Price
$6.27Prev Close
$6.37Open
$6.3950D MA
$5.74Beta
0.56Avg. Volume
139,885.97EPS (Annual)
-$1.68P/B
4.42Rev/Employee
$468,118.42$60.01
Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Short Interest Update
Verrica Pharmaceuticals Inc. (NASDAQ:VRCA - Get Free Report) was the recipient of a significant growth in short interest during the month of April. As of April 15th, there was short interest totaling 581,329 shares, a growth of 16.8% from the March 31st total of 497,753 shares. Based on an average...
MarketBeat·1d ago
Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Given Consensus Rating of "Reduce" by Brokerages
Verrica Pharmaceuticals Inc. (NASDAQ:VRCA - Get Free Report) has earned an average rating of "Reduce" from the four ratings firms that are currently covering the company, MarketBeat.com reports. Two...
MarketBeat·15d ago
Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Sees Large Growth in Short Interest
Verrica Pharmaceuticals Inc. (NASDAQ:VRCA - Get Free Report) was the target of a large growth in short interest in March. As of March 13th, there was short interest totaling 478,579 shares, a growth...
MarketBeat·1mo ago
Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Given Average Recommendation of "Hold" by Analysts
Shares of Verrica Pharmaceuticals Inc. (NASDAQ:VRCA - Get Free Report) have received a consensus rating of "Hold" from the five analysts that are covering the stock, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, three have issued a hold recommendation an...
MarketBeat·1mo ago
VRCA Investors Have the Opportunity to Join Investigation of Verrica Pharmaceuticals Inc. with the Schall Law Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Verrica Pharmaceuticals Inc. (Verrica or the Company) (NASDAQ...
Business Wire·1mo ago
VRCA Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Verrica Pharmaceuticals Inc. VRCA
Rosen Law Firm, a global investor rights law firm, announces an investigation of potential breaches of fiduciary duties by the directors and officers of Verrica Pharmaceuticals Inc. (NASDAQ: VRCA...
Business Wire·1mo ago
Verrica Pharmaceuticals Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Verrica Pharmaceuticals Inc. VRCA
Rosen Law Firm, a global investor rights law firm, announces an investigation of potential breaches of fiduciary duties by the directors and officers of Verrica Pharmaceuticals Inc. (NASDAQ: VRCA...
Business Wire·1mo ago
Verrica Pharmaceuticals Q4 Earnings Call Highlights
Verrica Pharmaceuticals (NASDAQ:VRCA) used its fourth quarter and year-end 2025 corporate update call to highlight what management described as a fundamental business transformation driven by sharper...
MarketBeat·2mo ago
Verrica Pharmaceuticals (NASDAQ:VRCA) Announces Quarterly Earnings Results
Verrica Pharmaceuticals (NASDAQ:VRCA - Get Free Report) issued its quarterly earnings results on Wednesday. The company reported ($0.51) earnings per share (EPS) for the quarter, missing the...
MarketBeat·2mo ago
Verrica Pharmaceuticals (NASDAQ:VRCA) Downgraded by Zacks Research to Hold
Zacks Research lowered shares of Verrica Pharmaceuticals from a "strong-buy" rating to a "hold" rating in a report on Monday...
MarketBeat·2mo ago
<
1
2
...
>